310 related articles for article (PubMed ID: 33857195)
1. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya.
Wanga V; Peebles K; Obiero A; Mogaka F; Omollo V; Odoyo JB; Morton JF; Bukusi EA; Celum C; Baeten JM; Barnabas RV
PLoS One; 2021; 16(4):e0249625. PubMed ID: 33857195
[TBL] [Abstract][Full Text] [Related]
2. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.
Roberts DA; Barnabas RV; Abuna F; Lagat H; Kinuthia J; Pintye J; Bochner AF; Forsythe S; Gomez GB; Baeten JM; John-Stewart G; Levin C
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25296. PubMed ID: 31328443
[TBL] [Abstract][Full Text] [Related]
3. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
[TBL] [Abstract][Full Text] [Related]
4. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: "What Is This PrEP?"-Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya.
Dettinger JC; Pintye J; Dollah A; Awuor M; Abuna F; Lagat H; Kohler P; John-Stewart G; O'Malley G; Kinuthia J; Beima-Sofie K
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):356-360. PubMed ID: 34379606
[TBL] [Abstract][Full Text] [Related]
6. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
[TBL] [Abstract][Full Text] [Related]
7. Estimating the costs and perceived benefits of oral pre-exposure prophylaxis (PrEP) delivery in ten counties of Kenya: a costing and a contingent valuation study.
Forsythe S; Kioko U; Mahiane G; Glaubius R; Musau A; Gichangi A; Reed J; Were D
Front Reprod Health; 2024; 6():1278764. PubMed ID: 38463424
[TBL] [Abstract][Full Text] [Related]
8. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
[TBL] [Abstract][Full Text] [Related]
9. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
[TBL] [Abstract][Full Text] [Related]
10. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
[TBL] [Abstract][Full Text] [Related]
11. Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya.
Omollo V; Roche SD; Mogaka F; Odoyo J; Barnabee G; Bukusi EA; Katz AWK; Morton J; Johnson R; Baeten JM; Celum C; O'Malley G
Sex Reprod Health Matters; 2022 Dec; 30(1):2095707. PubMed ID: 36169648
[TBL] [Abstract][Full Text] [Related]
12. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector.
Peebles K; Mugwanya KK; Irungu E; Odoyo J; Wamoni E; Morton JF; Ngure K; Bukusi EA; Mugo NR; Masyuko S; Mukui I; Baeten JM; Barnabas RV;
BMC Health Serv Res; 2021 Aug; 21(1):823. PubMed ID: 34399736
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
14. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
[TBL] [Abstract][Full Text] [Related]
15. Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study.
Mudimu E; Sardinia J; Momin S; Medina-Marino A; Bezuidenhout C; Bekker LG; Barnabas RV; Peebles K
J Int AIDS Soc; 2022 Feb; 25(2):e25875. PubMed ID: 35129299
[TBL] [Abstract][Full Text] [Related]
16. Standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial.
Larsen A; Wilson KS; Kinuthia J; John-Stewart G; Richardson BA; Pintye J; Abuna F; Lagat H; Owens T; Kohler P
BMJ Open; 2020 Jun; 10(6):e035689. PubMed ID: 32565464
[TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
[TBL] [Abstract][Full Text] [Related]
18. Uptake and continuation of HIV pre-exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya.
Ogolla M; Nyabiage OL; Musingila P; Gachau S; Odero TMA; Odoyo-June E; Ochanda B; Appolonia A; Katiku E; Joseph R; Ogolla C; Otieno L; Odhiambo F; Truong HM
J Int AIDS Soc; 2023 Mar; 26(3):e26069. PubMed ID: 36912204
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
20. Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.
Hendrickson C; Hirasen K; Mongwenyana C; Benade M; Bothma R; Smith C; Meyer J; Nichols B; Long L
medRxiv; 2023 Aug; ():. PubMed ID: 37645864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
